{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:46:17Z","timestamp":1789753577384,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000304","name":"Parkinson's UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000304","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lily and Edmond J. Safra Foundation"},{"name":"European Union FP-7 scheme"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.parkreldis.2019.04.026","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T18:05:42Z","timestamp":1557338742000},"page":"256-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Speech difficulties in early de novo patients with Parkinson's disease"],"prefix":"10.1016","volume":"64","author":[{"given":"Sotirios","family":"Polychronis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Niccolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6247-8988","authenticated-orcid":false,"given":"Gennaro","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyabah","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Politis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2019.04.026_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1044\/jshd.4301.47","article-title":"Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients","volume":"43","author":"Logemann","year":"1978","journal-title":"J. Speech Hear. Disord."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1121\/1.3514381","article-title":"Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease","volume":"129","author":"Rusz","year":"2011","journal-title":"J. Acoust. Soc. Am."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib3","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/mds.23290","article-title":"The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson's disease","volume":"25","author":"Sung","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bandc.2004.05.002","article-title":"Variability in fundamental frequency during speech in prodromal and incipient Parkinson's disease: a longitudinal case study","volume":"56","author":"Harel","year":"2004","journal-title":"Brain Cogn."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1474-4422(04)00854-3","article-title":"Treatments for dysarthria in Parkinson's disease","volume":"3","author":"Pinto","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib6","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1212\/WNL.51.6.1592","article-title":"Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging","volume":"51","author":"Baker","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.04.026_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcomdis.2004.09.001","article-title":"The effects of levodopa on word intelligibility in Parkinson's disease","volume":"38","author":"De Letter","year":"2005","journal-title":"J. Commun. Disord."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib8","first-page":"237","article-title":"Acoustic analysis of parkinsonian speech I: speech characteristics and L-Dopa therapy","volume":"17","author":"Goberman","year":"2002","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.parkreldis.2019.04.026_bib9","first-page":"19","article-title":"Levodopa-induced alterations in speech rate in advanced Parkinson's disease","volume":"106","author":"De Letter","year":"2006","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/mds.21899","article-title":"For better or worse: the effect of levodopa on speech in Parkinson's disease","volume":"23","author":"Ho","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1212\/WNL.54.2.458","article-title":"Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease","volume":"54","author":"Kompoliti","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.04.026_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.clineuro.2007.04.003","article-title":"The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease","volume":"109","author":"De Letter","year":"2007","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib13","first-page":"35","article-title":"The effects of levodopa on tongue strength and endurance in patients with Parkinson's disease","volume":"103","author":"De Letter","year":"2003","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00702-012-0853-4","article-title":"Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy","volume":"120","author":"Rusz","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032132","article-title":"Impairment of vowel articulation as a possible marker of disease progression in Parkinson's disease","volume":"7","author":"Skodda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2019.04.026_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","article-title":"The Parkinson progression marker initiative (PPMI)","volume":"95","author":"Parkinson Progression Marker","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1353-8020(99)00051-6","article-title":"Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis","volume":"6","author":"Schiess","year":"2000","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib18","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2019.04.026_bib19","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/brain\/awv215","article-title":"Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease","volume":"138","author":"Qamhawi","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.04.026_bib20","doi-asserted-by":"crossref","first-page":"e894","DOI":"10.1212\/WNL.0000000000006134","article-title":"REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease","volume":"91","author":"Pagano","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.04.026_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00702-016-1515-8","article-title":"Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients","volume":"123","author":"Rusz","year":"2016","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10072-013-1519-1","article-title":"Gait freezing and speech disturbance in Parkinson's disease","volume":"35","author":"Park","year":"2014","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jvoice.2009.07.005","article-title":"Gender-related patterns of dysprosody in Parkinson disease and correlation between speech variables and motor symptoms","volume":"25","author":"Skodda","year":"2011","journal-title":"J. Voice"},{"key":"10.1016\/j.parkreldis.2019.04.026_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.parkreldis.2016.08.013","article-title":"Speech and gait in Parkinson's disease: when rhythm matters","volume":"32","author":"Ricciardi","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1212\/WNL.60.3.432","article-title":"Hypophonia in Parkinson's disease: neural correlates of voice treatment revealed by PET","volume":"60","author":"Liotti","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.04.026_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/hbm.20859","article-title":"Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance-correlation analysis","volume":"31","author":"Narayana","year":"2010","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1044\/1058-0360(2008\/08-0004)","article-title":"A noninvasive imaging approach to understanding speech changes following deep brain stimulation in Parkinson's disease","volume":"18","author":"Narayana","year":"2009","journal-title":"Am. J. Speech Lang. Pathol"},{"key":"10.1016\/j.parkreldis.2019.04.026_bib28","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/brain\/awh074","article-title":"Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study","volume":"127","author":"Pinto","year":"2004","journal-title":"Brain"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2019.04.026_bib29","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.parkreldis.2015.09.006","article-title":"Impact of Parkinson's disease and levodopa on resting state functional connectivity related to speech prosody control","volume":"22","author":"Elfmarkova","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046541","article-title":"Levodopa effects on hand and speech movements in patients with Parkinson's disease: a FMRI study","volume":"7","author":"Maillet","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2019.04.026_bib31","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/mds.23439","article-title":"Instability of syllable repetition in Parkinson's disease--influence of levodopa and deep brain stimulation","volume":"26","author":"Skodda","year":"2011","journal-title":"Mov. Disord. : Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib32","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00415-009-5174-7","article-title":"How do cognitive and axial motor signs correlate in Parkinson's disease? A 6-year prospective study","volume":"256","author":"Gago","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.04.026_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.parkreldis.2016.05.018","article-title":"Speech prosody impairment predicts cognitive decline in Parkinson's disease","volume":"29","author":"Rektorova","year":"2016","journal-title":"Park. Relat. Disord."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019302214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019302214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:17:27Z","timestamp":1761178647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802019302214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":33,"alternative-id":["S1353802019302214"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.04.026","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Speech difficulties in early de novo patients with Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}